Illumina's Q3 Revenues Rise 21 Percent
October 24, 2012
Illumina's Q3 Revenues Rise 21 Percent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Illumina Posts 3 Percent Revenue Decline for Q1, as Asia Sales Surge
April 24, 2012 / GenomeWeb Daily News - Aiming at '$12B Opportunity,' Illumina to Expand Sales Presence, Invest in Reproductive Health
May 14, 2013 / BioArray News - Fluidigm Reports 33 Percent Spike in Q1 Revenues
May 2, 2013 / GenomeWeb Daily News - GenomeWeb Feature: New Techniques Driving Research into Epigenetic Changes in Cancer
April 16, 2013 / GenomeWeb Daily News - Survey Offers 'Cautious Array Forecast' for Illumina as Sequencing, Affymetrix Products Gain Ground
April 16, 2013 / BioArray News